Progressive multifocal leukoencephalopathy in a patient with multiple myeloma

Masaru Akiyama1, Toru Takahashi, Sinjo Nomura

  • 1Department of Hematology, Tokuyama Central Hospital, 1-1 Koda, Shunan, Yamaguchi, Japan.

Insights

Progressive multifocal leukoencephalopathy (PML), a rare brain infection, occurred in an immunodeficient patient with multiple myeloma (MM). Early diagnosis is crucial for MM patients presenting with neurological symptoms.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Oncology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic demyelinating disease affecting the central nervous system.
  • PML primarily impacts individuals with compromised immune systems, including those with hematological malignancies like multiple myeloma (MM).

Observation:

  • A 64-year-old male diagnosed with IgD type multiple myeloma (MM) presented with progressive neurological deficits.
  • Brain MRI revealed a characteristic hyperintense, non-enhancing lesion in the left frontal lobe.
  • Cerebrospinal fluid analysis confirmed the presence of John Cunningham virus (JCV) DNA via polymerase chain reaction.

Findings:

  • Histopathological examination of autopsy brain tissue demonstrated JCV DNA within the nuclei of oligodendroglia, confirming PML.
  • The case highlights a rare occurrence of PML in the context of multiple myeloma.

Implications:

  • This case underscores the importance of considering PML in multiple myeloma patients exhibiting neurological symptoms.
  • Prompt diagnostic workup, including JCV DNA testing and neuroimaging, is recommended for early detection and management.
  • Raising awareness of PML as a potential complication in MM patients can lead to improved patient outcomes.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...